Frank Morich

Insider Reports History

Location
40 Guest Street, Boston, MA
Signature
/s/ Frank Morich by Chris Nenno, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Morich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Perspective Therapeutics, Inc. Director Stock option (right to buy) 50K Mar 3, 2025 Direct
Cue Biopharma, Inc. Director Stock Option (right to buy) 24.4K Jan 2, 2025 Direct

Insider Reports Filed by Frank Morich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CATX Perspective Therapeutics, Inc. Mar 3, 2025 1 $0 4 Mar 5, 2025 Director
CUE Cue Biopharma, Inc. Jan 2, 2025 1 $0 4 Jan 3, 2025 Director
CATX Perspective Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
CUE Cue Biopharma, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
CATX Perspective Therapeutics, Inc. Dec 12, 2023 1 $0 4 Dec 14, 2023 Director
CATX Perspective Therapeutics, Inc. Feb 21, 2023 2 $0 4 Feb 23, 2023 Director
CATX Isoray, Inc. Feb 3, 2023 0 $0 3 Feb 13, 2023 Director
CUE Cue Biopharma, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
CUE Cue Biopharma, Inc. May 27, 2022 1 $105K 4 May 31, 2022 Director
CUE Cue Biopharma, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director